SGHT (Sight Sciences, Inc) Market Value to Book Value Ratio

Sight Sciences, Inc (SGHT) - corporate logo

Sight Sciences, Inc. (SGHT) focuses on surgeon training and attracting experienced sales representatives through an option system. Ownership of the unique OMNI technology simplifies glaucoma surgeries, guaranteeing the firm high profitability. The share price retrospective on GURU.Markets recorded a value of 9.60. A stable cash flow is driven by the expanding number of microsurgical interventions, while insurance risks have already been priced in by investors.

Market Capitalization to Net Assets: Sight Sciences Inc (SGHT) for 07/04/2022 - 10/29/2026

SGHT (Sight Sciences Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Quotes Sight Sciences, Inc.|SGHT - Analyst Forecast Prices
- market capitalization data:
Market Value Sight Sciences, Inc|SGHT - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Sight Sciences, Inc.|SGHT - Net Asset Value|Market Capitalization to Book Value Ratio sightsciences.com|SGHT - Company Assets
- debt and liquidity data:
Total Debt to Capital Sight Sciences, Inc.|SGHT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Sight Sciences, Inc|SGHT - Company Total Debt Obligations|Debts to Book Capitalization Sight Sciences, Inc|SGHT - Company Long-Term Debts|Company Short-Term Debt Sight Sciences, Inc.
Initial company analysis:Sight Sciences, Inc. - SGHT
Finished products of Sight Sciences Inc.

This ratio compares the market value of Sight Sciences, Inc. (SGHT) with its net assets, determining the extent of the premium or discount to equity and confirming the quality of the assets. By analyzing the chart of market and book valuation metrics, an investor can assess the scaling efficiency of glaucoma surgery systems and the potential for achieving profitability through the expansion of insurance coverage in the US.

Direct competitors

BSX - Market Cap to Net Assets Ratio|EW (edwards.com) - Market Cap to Book Value Multiple|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio OrthoPediatrics Corp (KIDS)|Capitalization to Book Value Ratio Treace Corp (TMCI)|Strata Critical Medical Inc (SRTA) - Market Cap to Net Assets Ratio|Market Value to Book Value CARL (carlsmed.com)|RxSight - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio ClearPoint Neuro Inc. CLPT|STXS (Stereotaxis Corp) - Market Capitalization to Book Value Ratio|STIM - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO